Investigating the Association of TaqI (rs731236), ApaI (rs7975232), and BsmI (rs1544410) With Diabetic Nephropathy: A Case for Broader Genetic and Epigenetic Research

Dear Editor, Globally, as diabetes and type 2 diabetic nephropathy (T2DN) continue to rise, a personalized approach to diabetes care is increasingly necessary. The study by Esha B et al.[1] on vitamin D receptor (VDR) gene polymorphisms offer credible information into genetic risk assessment and therapeutic potential, focusing on three common polymorphisms (TaqI, BsmI, and ApaI) in a South Indian cohort. However, their results revealed no significant association between these polymorphisms and diabetic nephropathy, opening the door for further research into additional genetic and epigenetic pathways that might influence this disease. The role of genetic variants in diabetes-related complications is multifaceted. While the authors’ findings are commendable, further exploration of VDR’s role in immune regulation and inflammatory pathways could provide a more elaborate understanding of T2DN. For example, VDR has been shown to influence the renin–angiotensin system, a crucial regulator of kidney function and blood pressure. Understanding how it modulates downstream immune and kidney-related pathways could help expand our knowledge of diabetic nephropathy mechanisms.[1] While the study focused on genetic factors, it is equally important to consider epigenetic mechanisms like deoxyribonucleic acid methylation and histone modification, which have been shown to affect VDR expression and vitamin D metabolism in diabetic patients. Investigating these epigenetic changes alongside VDR polymorphisms could provide a more holistic understanding of its role in diabetic kidney disease progression.[2] The authors’ genetic findings could also be strengthened by examining their therapeutic implications. Although the study did not find a direct link between VDR polymorphisms and nephropathy, previous research suggests that activating the VDR pathway through vitamin D supplementation or analogs like calcitriol may reduce proteinuria and improve glomerular filtration rates in chronic kidney disease patients. Thus, therapeutic interventions targeting the VDR pathway could still hold potential, even without specific genetic predispositions, including such insights, would enhance the clinical relevance of the findings.[3] The study’s focus on vitamin D and nephropathy brings attention to the broader relationship between vitamin D deficiency and kidney health. Though no significant differences in vitamin D levels were found based on VDR genotypes, the interaction between vitamin D status, insulin resistance, and lipid metabolism in diabetic patients remains complex. Future studies could stratify participants by glycemic control, hypertension, and lipid profiles to better understand the interactions between vitamin D deficiency, VDR polymorphisms, and nephropathy.[4] The authors’ recognition of population-specific variations in VDR polymorphisms is critical. Genetic studies on VDR polymorphisms have yielded mixed results across populations, highlighting the need for comparative studies across diverse ethnic groups. Expanding this research to include other regions such as North India, East Asia, and the Middle East would provide a broader understanding of VDR’s role in nephropathy risk. Exploring haplotypes or gene–gene interactions could uncover subtle genetic influences that single nucleotide polymorphism analyses may overlook.[5] While this study provides valuable genetic discoveries, there are exciting opportunities to explore epigenetic changes, therapeutic interventions, and population-specific variations further. These approaches could deepen our understanding of diabetic nephropathy and improve clinical outcomes for patients. Acknowledgements I would like to acknowledge the authors of the original study, Esha et al. for their significant contribution to the field of diabetic nephropathy research. Their work on vitamin D receptor polymorphisms has provided a valuable foundation for further discussion and exploration. Author contributions As the sole author, I, Muhammed Ali Siham was responsible for the conception, drafting, critical review, and finalization of this letter. Ethical approval Ethical approval was not required for this letter as it is only a commentary on previously published research. The original study referenced was conducted following all relevant ethical guidelines as stated by the authors. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.